Skip to main content
. 2024 Feb 14;14(2):e079309. doi: 10.1136/bmjopen-2023-079309

Figure 2.

Figure 2

Trial design. Overview of the trial design. ALB-TRIAL is a multinational trial with recruiting sites from Spain, Germany, Belgium, Hungary, the UK, Denmark and the Netherlands. In total, 240 participants will be enrolled and undergo a biomarker-based stratification according to their expected response to human albumin infusions, before they are randomisation into an active treatment group (albumin) or corresponding placebo (saline). SMT, standard medical treatment.